Skip to main content

UBS Group AG

Position in LFCR — Lifecore Biomedical, Inc. \De\

CIK 1610520 ZURICH, V8

Position in LFCR

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$260,370
-$187,573 QoQ
Shares Held
69,992
+27.8% QoQ
Ownership
0.187%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LFCR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

UBS Group AG holds $1,523,036,852 across 81 Drug Manufacturers - Specialty & Generic names. LFCR ranks #51 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LFCR

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $260,370 69,992
2025-12-31 $447,943 54,761
2025-09-30 $683,213 92,828
2025-06-30 $784,804 96,651
2025-03-31 $775,926 110,217
2024-12-31 $809,728 108,981
2024-09-30 $177,928 36,091
2024-06-30 $173,696 33,859
2024-03-31 $131,629 24,789
2023-12-31 $468,979 75,764
2023-09-30 $615,559 81,531
2023-06-30 $48,350 5,000
2023-03-31 $117,818 31,169
2022-12-31 $191,172 29,502
2022-09-30 $203,696 22,913
2022-06-30 $230,406 23,110
2022-03-31 $343,010 29,621
2021-12-31 $524,041 47,211
2021-09-30 $324,912 35,240
2021-06-30 $385,492 34,266
2021-03-31 $475,473 44,856
2020-12-31 $340,538 31,386
2020-09-30 $245,896 25,298
2020-06-30 $254,879 32,020
2020-03-31 $275,142 31,662